Open AccessLaparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)
Author(s) -
Roni Nitecki,
José Alejandro Rauh-Hain,
Alexander Melamed,
Giovanni Scambia,
René Pareja,
Robert L. Coleman,
Pedro T. Ramírez,
Anna Fagotti
Publication year - 2020
Publication title -
international journal of gynecological cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.901
H-Index - 87
eISSN - 1525-1438
pISSN - 1048-891X
DOI - 10.1136/ijgc-2020-001584
Subject(s) - medicine , debulking , laparotomy , surgery , chemotherapy , ovarian cancer , laparoscopy , randomized controlled trial , neoadjuvant therapy , stage (stratigraphy) , cancer , breast cancer , paleontology , biology
Observational studies have supported the practice of offering minimally invasive interval debulking surgery after neoadjuvant chemotherapy for well-selected patients with advanced epithelial ovarian cancer. However, there are no prospective randomized data comparing the oncologic efficacy of minimally invasive and open interval debulking surgery in epithelial ovarian cancer.